945 related articles for article (PubMed ID: 29504847)
1. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Merker JD; Oxnard GR; Compton C; Diehn M; Hurley P; Lazar AJ; Lindeman N; Lockwood CM; Rai AJ; Schilsky RL; Tsimberidou AM; Vasalos P; Billman BL; Oliver TK; Bruinooge SS; Hayes DF; Turner NC
J Clin Oncol; 2018 Jun; 36(16):1631-1641. PubMed ID: 29504847
[TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Merker JD; Oxnard GR; Compton C; Diehn M; Hurley P; Lazar AJ; Lindeman N; Lockwood CM; Rai AJ; Schilsky RL; Tsimberidou AM; Vasalos P; Billman BL; Oliver TK; Bruinooge SS; Hayes DF; Turner NC
Arch Pathol Lab Med; 2018 Oct; 142(10):1242-1253. PubMed ID: 29504834
[TBL] [Abstract][Full Text] [Related]
3. Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
van Dessel LF; Beije N; Helmijr JC; Vitale SR; Kraan J; Look MP; de Wit R; Sleijfer S; Jansen MP; Martens JW; Lolkema MP
Mol Oncol; 2017 Mar; 11(3):295-304. PubMed ID: 28164427
[TBL] [Abstract][Full Text] [Related]
4. The cornerstone of integrating circulating tumor DNA into cancer management.
Li Z; Yi L; Gao P; Zhang R; Li J
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):1-11. PubMed ID: 30419316
[TBL] [Abstract][Full Text] [Related]
5. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
Chen X; Wang L; Lou J
Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
8. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.
Pascual J; Attard G; Bidard FC; Curigliano G; De Mattos-Arruda L; Diehn M; Italiano A; Lindberg J; Merker JD; Montagut C; Normanno N; Pantel K; Pentheroudakis G; Popat S; Reis-Filho JS; Tie J; Seoane J; Tarazona N; Yoshino T; Turner NC
Ann Oncol; 2022 Aug; 33(8):750-768. PubMed ID: 35809752
[TBL] [Abstract][Full Text] [Related]
9. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.
Chaudhuri AA; Binkley MS; Osmundson EC; Alizadeh AA; Diehn M
Semin Radiat Oncol; 2015 Oct; 25(4):305-12. PubMed ID: 26384278
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Gingras I; Salgado R; Ignatiadis M
Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
[No Abstract] [Full Text] [Related]
12. Assessment of circulating copy number variant detection for cancer screening.
Molparia B; Nichani E; Torkamani A
PLoS One; 2017; 12(7):e0180647. PubMed ID: 28686671
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of circulating tumor DNA stability In K
Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M
Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Assays in Clinical Cancer Research.
Ossandon MR; Agrawal L; Bernhard EJ; Conley BA; Dey SM; Divi RL; Guan P; Lively TG; McKee TC; Sorg BS; Tricoli JV
J Natl Cancer Inst; 2018 Sep; 110(9):929-934. PubMed ID: 29931312
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
Calapre L; Warburton L; Millward M; Ziman M; Gray ES
Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.
Cheng ML; Pectasides E; Hanna GJ; Parsons HA; Choudhury AD; Oxnard GR
CA Cancer J Clin; 2021 Mar; 71(2):176-190. PubMed ID: 33165928
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy: unlocking the potentials of cell-free DNA.
Chu D; Park BH
Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
[TBL] [Abstract][Full Text] [Related]
19. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.
Siravegna G; Bardelli A
Mol Oncol; 2016 Mar; 10(3):475-80. PubMed ID: 26774880
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Treatment Stratification Using ctDNA.
Vidal J; Taus A; Montagut C
Recent Results Cancer Res; 2020; 215():263-273. PubMed ID: 31605234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]